Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association

BW McCrindle, AH Rowley, JW Newburger, JC Burns… - circulation, 2017 - Am Heart Assoc
Background: Kawasaki disease is an acute vasculitis of childhood that leads to coronary
artery aneurysms in≈ 25% of untreated cases. It has been reported worldwide and is the …

Kawasaki disease

JW Newburger, M Takahashi, JC Burns - Journal of the American College …, 2016 - jacc.org
Kawasaki disease is an acute, self-limited vasculitis of unknown etiology that occurs
predominantly in infants and children. If not treated early with high-dose intravenous …

Kawasaki syndrome

JC Burns, MP Glodé - The Lancet, 2004 - thelancet.com
Kawasaki syndrome is an acute, self-limited vasculitis that occurs in children of all ages and
presents a challenge for the clinician: the disorder can be difficult to recognise; there is no …

Management of Kawasaki disease

D Eleftheriou, M Levin, D Shingadia, R Tulloh… - Archives of disease in …, 2014 - adc.bmj.com
Kawasaki disease (KD) is an acute self-limiting inflammatory disorder, associated with
vasculitis, affecting predominantly medium-sized arteries, particularly the coronary arteries …

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial

AH Tremoulet, S Jain, P Jaggi, S Jimenez-Fernandez… - The Lancet, 2014 - thelancet.com
Background Kawasaki disease, the most common cause of acquired heart disease in
developed countries, is a self-limited vasculitis that is treated with high doses of intravenous …

Hypercytokinemia in familial hemophagocytic lymphohistiocytosis

JI Henter, G Elinder, O Soder, M Hansson… - 1991 - ashpublications.org
Familial hemophagocytic lymphohistiocytosis (FHL) is a frequently missed and almost
uniformly fatal childhood disorder. It is characterized by fever, hepatosplenomegaly …

[HTML][HTML] Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization

HA Hennein, H Ebba, JL Rodriguez, SH Merrick… - The Journal of thoracic …, 1994 - Elsevier
The proinflammatory cytokines have been implicated in mediating myocardial dysfunction
associated with myocardial infarction, severe congestive heart failure, and sepsis. We tested …

Kawasaki disease: a brief history

JC Burns, HI Kushner, JF Bastian, H Shike… - …, 2000 - publications.aap.org
Tomisaku Kawasaki published the first English-language report of 50 patients with Kawasaki
disease (KD) in 1974. Since that time, KD has become the leading cause of acquired heart …

Infliximab treatment of intravenous immunoglobulin–resistant Kawasaki disease

JC Burns, BM Best, A Mejias, L Mahony, DE Fixler… - The Journal of …, 2008 - Elsevier
OBJECTIVE: To investigate the safety, tolerability, and pharmacokinetics of the anti–tumor
necrosis factor-α monoclonal antibody infliximab in subjects with intravenous …

Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease.

J Abe, BL Kotzin, K Jujo, ME Melish… - Proceedings of the …, 1992 - National Acad Sciences
Kawasaki disease (KD) is an acute vasculitis complicated by the development of coronary
artery abnormalities. The etiology of KD is unknown. Based on the observation that KD is …